BioLineRx (BLRX) Notes Payables (2012 - 2018)
BioLineRx (BLRX) posted Notes Payables of $93000.0 for Q3 2018, little changed on a QoQ basis from $93000.0 in Q2 2018, and little changed year-over-year from $93000.0 in Q3 2017.
BioLineRx (BLRX) has 6 years of Notes Payables data on file, last reported at $93000.0 in Q3 2018.
- In Q3 2018, Notes Payables changed 0.0% year-over-year to $93000.0; the TTM figure through Sep 2018 stood at $93000.0 (changed 0.0% YoY), while the FY2017 annual figure was $93000.0, changed 0.0% from the prior year.
- Notes Payables held at $93000.0 in Q3 2018, from $93000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $93000.0 in Q3 2015 and bottomed at $93000.0 in Q3 2015.
- A 4-year average of $93000.0 and a median of $93000.0 in 2015 frame the typical range for Notes Payables.
- The widest YoY moves for Notes Payables: up 0.0% in 2016, down 0.0% in 2016.
- Year by year, Notes Payables stood at $93000.0 in 2015, then changed by 0.0% to $93000.0 in 2016, then changed by 0.0% to $93000.0 in 2017, then changed by 0.0% to $93000.0 in 2018.
- The last three Notes Payables figures came in at $93000.0 (Q3 2018), $93000.0 (Q2 2018), and $93000.0 (Q1 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 93,000.00 |
| Jun 30, 2018 | 93,000.00 |
| Mar 31, 2018 | 93,000.00 |
| Dec 31, 2017 | 93,000.00 |
| Sep 30, 2017 | 93,000.00 |
| Jun 30, 2017 | 93,000.00 |
| Mar 31, 2017 | 93,000.00 |
| Dec 31, 2016 | 93,000.00 |
| Sep 30, 2016 | 93,000.00 |
| Jun 30, 2016 | 93,000.00 |
| Mar 31, 2016 | 93,000.00 |
| Dec 31, 2015 | 93,000.00 |
| Sep 30, 2015 | 93,000.00 |
| Mar 31, 2013 | 15,000.00 |
| Dec 31, 2012 | 37,000.00 |